Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07661849 · ClinicalTrials.gov registry record · NA
Efficacy of Tele-CPASS Compared to In-person CPASS Therapy for Upper Extremity Motor Recovery
A NA study, sponsored by University of Texas, El Paso.
- Recruiting
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT07661849 is a NA study that is actively recruiting participants, run by University of Texas, El Paso. The registered enrollment target is 42 participants.
The verdict
NCT07661849, a NA study, is actively recruiting participants, sponsored by University of Texas, El Paso.
- RECRUITING
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
This study evaluates whether a home-based telerehabilitation program (tele-CPASS) is as effective as an in-person rehabilitation program (CPASS) for improving arm and hand function after stroke. Stroke often leads to long-term difficulty using the affected arm in daily activities, and access to in-person therapy can be limited. This study aims to determine whether therapy delivered remotely can provide similar benefits to standard in-clinic care. Participants who recently experienced a stroke will be randomly assigned to receive 20 hours of upper extremity rehabilitation therapy either in person or through a telehealth platform. Both groups will receive the same type and amount of therapy focused on practicing meaningful, patient-selected daily activities. Participants will complete assessments before treatment, immediately after treatment, and at 6 and 12 months to measure recovery of arm function, real-world arm use, and participation in daily life. The results of this study will help determine whether telerehabilitation can improve access to effective stroke recovery interventions while maintaining clinical effectiveness comparable to in-person therapy.
Interventions
- BEHAVIORAL Tele-CPASS
- BEHAVIORAL In-person CPASS therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2025-09-01 |
| Est. Completion | 2029-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07661849
The ClinicalTrials.gov registry entry for NCT07661849 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas, El Paso, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tele-CPASS is the first listed.
NCT07661849 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07661849 about?
NCT07661849 is a clinical study titled "Efficacy of Tele-CPASS Compared to In-person CPASS Therapy for Upper Extremity Motor Recovery". This study evaluates whether a home-based telerehabilitation program (tele-CPASS) is as effective as an in-person rehabilitation program (CPASS) for improving arm and hand function after stroke. Stroke often leads to long-term difficulty using the affected arm in daily activities, and access to in-p...
What is the current status of trial NCT07661849?
This trial is currently recruiting. It is a NA study. The enrollment target is 42 participants. The study started on 2025-09-01. Estimated completion is 2029-08-31.
What interventions are being tested in trial NCT07661849?
The interventions under investigation include: Tele-CPASS (BEHAVIORAL), In-person CPASS therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT07661849?
This trial is sponsored by University of Texas, El Paso, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.